Vera Therapeutics Valuation Multiples

Vera Therapeutics Overview

About Vera Therapeutics

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Founded

2016

HQ

Employees

112

Website

veratx.com

Sectors

BiopharmaceuticalsBioTech

Financials (LTM)

Revenue: $12M

EBITDA: ($321M)

EV

$2B

Valuation Multiples

Multiples.vc

Start free trial

Vera Therapeutics Financials

Vera Therapeutics reported last 12-month revenue of $12M and negative EBITDA of ($321M).

In the same LTM period, Vera Therapeutics generated $11M in gross profit, ($321M) in EBITDA losses, and had net loss of ($318M).

Vera Therapeutics P&L

In the most recent fiscal year, Vera Therapeutics reported revenue of — and EBITDA of ($292M).

Vera Therapeutics expects next 12-month revenue of XXX and NTM EBITDA of XXX

Vera Therapeutics Stock Performance

Vera Therapeutics has current market cap of $3B, and enterprise value of $2B.

Vera Therapeutics' stock price is $40.93.

Vera Therapeutics Valuation Multiples

Vera Therapeutics trades at 195.8x EV/Revenue multiple, and (7.1x) EV/EBITDA.

Vera Therapeutics Financial Valuation Multiples

As of April 11, 2026, Vera Therapeutics has market cap of $3B and EV of $2B.

Equity research analysts estimate Vera Therapeutics' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Vera Therapeutics has a P/E ratio of (9.2x).

Vera Therapeutics Margins & Growth Rates

Vera Therapeutics' revenue in the last 12 month grew by 787%.

Vera Therapeutics' revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $2.8M for the same period.

Vera Therapeutics Public Comps

See public comps and valuation multiples for other Biopharmaceuticals comps.

Vera Therapeutics M&A Activity

Vera Therapeutics acquired XXX companies to date.

Last acquisition by Vera Therapeutics was on XXXXXXXX, XXXXX. Vera Therapeutics acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Vera Therapeutics Investment Activity

Vera Therapeutics invested in XXX companies to date.

Vera Therapeutics made its latest investment on XXXXXXXX, XXXXX. Vera Therapeutics invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).